# Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis

> **NCT03006016** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 44 (actual)

## Conditions studied

- Morbid Obesity D009765

## Interventions

- **DRUG:** Omega-3 Fatty Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03006016
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-08-07
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006016, "Preoperative Omega-3 Polyunsaturated Fatty Acids in Morbidly Obese to Reduce Liver Volume and Steatosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03006016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*